‒ The GP2 Phase III clinical trial design was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) and introduced by the Global Principal Investigator, Professor Mothaffar F. Rimawi ...
Poster PS5-08-16 Reports Early Observations from the INVINCIBLE-4 Study, an Ongoing Randomized, Presurgical Phase 2 Clinical Trial for Triple Negative Breast Cancer continue to show favorable safety ...
Poster Orientation describes how the poster will be displayed, and there are two options: Portrait and Landscape. Check for poster orientation requirements in poster session guidelines before ...
At AACR 2024, we explored the poster hall to pick out the posters that would interest the BioTechniques reader and those we found delivered the most interesting or surprising findings. Get our ...
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that four abstracts have been accepted as poster presentations ...
Last week, NPR’s "All Things Considered" covered an unusual topic: Scientific conference posters. For the first time in decades, scientists are rethinking the traditional design of the posters they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback